A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.
Adult females or males age ≥ 18 years
At least moderate gastrointestinal distress, defined as a score of ≥ 4 on any domain of the Gastrointestinal Symptoms Rating Scale (GSRS) at screening
Ability to read and speak English
Ability and willingness to collect an at-home stool sample for GI-MAP testing
Current or recent (within the prior 90 days) use of a probiotic dietary supplement
Current or recent (within the prior 90 days) use of systemic antibiotics, antifungals, or antiparasitic medications
Known allergies to any ingredients in the product
Currently pregnant or lactating women or women planning to become pregnant in the next 8 weeks